Related Experiment Video

Updated: May 23, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination

Fabian Benencia1, Leslee Sprague, John McGinty

  • 1Biomedical Engineering Program, Russ College of Engineering and Technology, Ohio University, Athens, OH 45701-2979, USA. benencia@oucom.ohiou.edu

Journal of Biomedicine & Biotechnology
|April 17, 2012
PubMed

Insights

Dendritic-cell-based vaccines show therapeutic potential for cancer patients. Strategies are discussed to enhance these vaccines by overcoming the tumor microenvironment's immunosuppressive effects.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Dendritic cells (DCs) are crucial antigen-presenting cells in anti-tumor immunity.
  • The tumor microenvironment (TME) often suppresses immune responses, including DC function.
  • Recent FDA approval highlights the clinical relevance of DC-based cancer vaccines.

Purpose of the Study:

  • To review DC characteristics and strategies for effective anti-tumor DC vaccine development.
  • To discuss the impact of the TME on DC function and anti-tumor immunity.
  • To explore methods for enhancing DC vaccine efficacy by modulating the TME.

Main Methods:

  • Review of existing literature on dendritic cells and cancer vaccines.
  • Analysis of the immunosuppressive mechanisms within the tumor microenvironment.
  • Discussion of novel strategies for DC vaccine optimization.

Main Results:

  • Dendritic cells play a key role in initiating anti-tumor immune responses.
  • The TME actively impairs DC function, promoting tumor growth.
  • Reprogramming the TME offers a promising approach to improve DC vaccine efficacy.

Conclusions:

  • DC-based vaccines represent a significant advancement in cancer immunotherapy.
  • Overcoming TME-mediated immunosuppression is critical for successful DC vaccination.
  • Future strategies should focus on enhancing DC function within the tumor context.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview